论文部分内容阅读
Ｐｒｏｇｒａｆ在日本获准用于肾移植的排斥反应藤泽公司（Ｆｕｊｉｓａｗａ）的免疫抑制剂Ｐｒｏ－ｇｒａｆ（ｔａｃｒｏｌｉｍｕｓ）最近在日本获准用于肾脏移植病人的排斥反应的治疗。这一新的适应症是于４月１６日获得卫生福利部（ＭＨＷ）同意的。Ｐｒｏｇｒａｆ与环...
Prograf approved for renal transplant rejection in Japan Fujisawa’s immunosuppressive agent Pro-graf (tacrolimus) was recently approved for the treatment of rejection in kidney transplant patients in Japan. This new indication was approved by the Ministry of Health and Welfare (MHW) on April 16. Prograf with ring ...